According to a Form 4 filing with the U.S. Securities and Exchange Commission (SEC), Doximity (NYSE:DOCS) director Timothy S. Cabral sold 7,500 shares of Class A common stock on August 7. This sale was automatically executed under a Rule 10b5-1 trading plan adopted on February 19, designed to avoid the influence of insider information. Despite the sale of some shares, Cabral still holds 3,221 shares of common stock and 326,000 derivative securities. Doximity is a company that provides a cloud-based digital platform for healthcare practitioners.